
Shuttle Pharmaceuticals fell 77.9% from $19.20 to $4.24, behind the S&P 500's +11.2%. Its worst day was May 1 (−33.5%), and its low came Jul 29 at $2.78.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Shuttle Pharmaceuticals shares fell 25.9%, while the S&P 500 rose 0.2%.
−25.9% · S&P 500 +0.2%
Shuttle Pharmaceuticals closed at its highest level of the year, 30.2% above where the year started.
Story events cover the past 12 months · Times ET
+5.9% · S&P 500 0.0%
Shuttle Pharmaceuticals shares fell 24.3%, while the S&P 500 fell 0.0%.
−24.3% · S&P 500 0.0%
EPS of $-9.40 was reported on $0.00 revenue.
−1.3% · S&P 500 +0.8%
Under the terms of the merger agreement, signed April 30, 2026, Shuttle will issue an aggregate of 8,000 of a newly designated Series B-1 Convertible Preferred Stock to United Dogecoin’s equity holders in exchange for
−33.5%, the year's worst day · S&P 500 +0.3%
EPS of $-4.30 was reported on $0.00 revenue.
−6.9% · S&P 500 −0.1%
Shuttle Pharmaceuticals shares rose 40.5%, while the S&P 500 rose 0.4%.
+40.5%, the year's best day, on 53M shares, the year's heaviest volume · S&P 500 +0.4%
Shuttle Pharmaceuticals closed at its lowest level of the year, 85.5% below where the year started.
−0.4% · S&P 500 −1.5%
EPS of $-3.10 was reported on $0.00 revenue.
+13.9% · S&P 500 −0.1%
Where it ended: a close of $4.24 on Nov 16, 2026. Up next: Q3 2026 earnings on Dec 1, 2026.
Nothing in the past 12 months.
All SHPH analyst actionsNothing in the past 12 months.
All SHPH dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SHPH and SPY from Benzinga historical bars. Not investment advice.